Technology
Health
Biotechnology

Moderna

$13.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.49 (3.87%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Moderna and other stocks, options, ETFs, and crypto commission-free!

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. Read More The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA. MRNA is listed on the OTCQB market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Employees
760
Headquarters
Cambridge, Massachusetts
Founded
2010
Market Cap
4.35B
Price-Earnings Ratio
Dividend Yield
Average Volume
1.33M
High Today
$13.24
Low Today
$12.79
Open Price
$12.85
Volume
1.11M
52 Week High
$29.79
52 Week Low
$11.54

Collections

Technology
Health
Biotechnology
Therapy
Cancer Prevention
2018 IPO
US
North America

MRNA Earnings

-$0.44
-$0.41
-$0.39
-$0.36
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.44 per share
Actual
-$0.41 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.